NIH researchers make AI tool to read cancer responses to immunotherapy
Researchers at the National Institutes of Health have developed an artificial intelligence tool that uses a simple blood test to predict if cancer.
Drugs
Health
Pharma
Drugs
Medical
Pharma
Merck’s Keytruda receives FDA nod for cervical cancer treatment
HQ Team January 13, 2024: The U.S. Food and Drug Administration (FDA) has granted approval for the expanded use of Merck & Co’s.
Drugs
Health
Pharma
ImmunoACT gets nod for leukaemia, lymphoma cancer therapy in India
HQ Team October 16, 2023: India’s Immunoactive Cell Therapy Ltd., has got a marketing authorisation from the drug regulator for a therapy to.
Drugs
Health
Pharma
Moderna, Immatics join hands to hunt for cancer therapies using mRNA, AI
HQ Team September 11, 2023: Moderna Inc. announced a pact with Immatics NV, a clinical-stage biopharmaceutical company, to develop cancer therapies using a.
Drugs
Health
Pharma
Anixa to conduct breast cancer trials with Merck’s Keytruda therapy
HQ Team August 7, 2023: Anixa Biosciences, Inc., announced that its partner Cleveland Clinic has begun enrolling subjects in a treatment arm to.
Drugs
Pharma
Merck to acquire Prometheus for $10.8 billion to step up immunology presence
HQ Team April 17, 2023: US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from.
Drugs
Health
Pharma
Embedded LEDs may aid future cancer immunotherapies
Activation of bio-therapeutic drugs by switching on LEDs embedded close to a tumour may be cancer immunotherapy's future, researchers found.
Drugs
Pharma
Israeli researchers develop artificially intelligent pathological assistants
Israeli researchers have succeeded in making computers into pathological assistants at a time when healthcare companies are trying to overcome a global shortage.